Clostridium difficile infection (CDI) is a severe bacterium that impacts hospitalized patients and significantly increases risk of death. Jvion’s CDI vector helps providers determine who is at-risk of a CDI and accounts for risks beyond the current patient to drive considerations for the 20-50% of asymptomatic patients that contribute to CDI risk
Clostridium difficile infections (CDIs) are on the rise in the United States. According to the Centers for Disease Control and Prevention, there are nearly half a million C. Difficile instances in a single year of which 15,000 deaths are directly attributable to the infection. Based on a study published by the National Center for Biotechnology Information (NCBI), the average cost per CDI per case ranges from $9,000 to $11,500. This adds up to $4.8 billion in excess cost and potential losses within just short-term acute care hospitals.
In response to growing need, Jvion activated a C. Difficile vector within the company’s leading Cognitive Clinical Success Machine. This vector, which is generally available, helps hospitals identify patients at risk of developing a C. Difficile infection during the hospital stay. Further differentiating the solution is its ability to provide the recommended actions that will most effectively reduce risk. The multidimensional view rendered for each patient includes an enterprise-wide, longitudinal dimension to account for the 20-50% of asymptomatic patients who can drive up risk across a hospital’s patient population but remain difficult to identify.
Dr. John Showalter, Jvion’s Chief Product Officer highlights, “The C. Difficile vector within the Cognitive Clinical Success Machine is really designed to deliver granular, patient-level information that is customizable to a specific population and tuned to a hospital’s operational needs.” He added, “Because the machine accounts for the invisible carriers of C. Difficile and the contributing risk factors driving an individual’s risk, hospitals are better able to work collaboratively to stop the actions that may be driving up risk and implement the actions that will help to stop what is a potentially deadly but avoidable infection.”
Jvion’s C. Difficile vector is one of thousands currently enabled within the Cognitive Clinical Success Machine. This machine, which relies on applied cognitive science techniques, is helping hospitals manage care across the continuum. From avoidable ER admissions to readmissions and chronic condition management, the Cognitive Clinical Success Machine is driving preventative, tailored medicine across diverse and ever changing patient populations.